Clinical trial
Montelukast in ENL Reaction
NCT00406861 · The Leprosy Mission Bangladesh, Other · Unknown status
Key facts
| NCT number | NCT00406861 |
|---|---|
| Title | Montelukast in ENL Reaction |
| Official title | Montelukast as an Alternative or Supplementary Treatment in ENL Reaction in Leprosy |
| Lead sponsor | The Leprosy Mission Bangladesh, Other |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Erythema Nodosum Leprosum, Leprosy |
| Intervention type | Drug |
| Interventions | montelukast in treatment of ENL reaction |
| Enrollment | 60 |
| Start date | Dec 1, 2006 |
| Completion | Jun 1, 2009 |
| First posted | Dec 4, 2006 |
| Last update posted | Dec 4, 2006 |
| Countries | Bangladesh |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: